Major Portfolio Boost
Rockefeller Capital Management Boosts Q4 Holdings, Significantly Increasing Stakes in Key ETFs and Ingevity Stock
Key Points
CGGO: Rockefeller Capital Management L.P. increased its Capital Group Global Growth Equity ETF stake by 62,320 shares in Q4, bringing total holdings to 166,190 shares and approximately $5.76 million in value.
CGGO: In addition to the share increase, CGGO opened at $41.19 on Friday and features a market cap around $11.15 billion, a P/E of 22.37, a beta of 1.02, and a 52-week range of $31.60 to $42.88.
GDXJ: Rockefeller boosted its stake by 24,127 shares in the fourth quarter, bringing total GDXJ holdings to 49,351 shares valued at about $5.62 million; GDXJ opened at $100.29, with a 50-day SMA of $114.31 and a 200-day SMA of $122.50, and it carries a market cap around $7.51 billion with a P/E near 24.09.
GCOW: Rockefeller raised its stake by 78,403 shares in GCOW, increasing total holdings to 144,415 shares worth about $5.95 million; GCOW opened at $43.66, with a 50-day moving average of $45.51, a 200-day moving average of $44.77, and a 12-month low/high of $37.70/$47.57, alongside a P/E of 12.82 and beta of 0.69.
NGVT: Rockefeller increased its NGVT position by 92,516 shares to total 94,830 shares, valued around $5.61 million; NGVT has drawn analyst attention with a Wall Street Zen upgrade to strong-buy, Wells Fargo lifting its price target to $75, and BMO reaffirming an outperform rating, with institutional investors owning about 91.59% of the stock.
Rockefeller Capital Management L.P. made a series of aggressive portfolio moves in the fourth quarter, more than doubling some positions and nearly quadrupling others, according to watchlistnews.com and tickerreport.com. The firm's most dramatic bet was a 3,998% surge in Ingevity Corporation (NGVT), jumping from a near-zero stake to 94,830 shares worth roughly $5.61 million.
Across ETFs, Rockefeller added to positions in global growth, precious metals, dividend income, and ESG funds. The moves signal a broad strategic shift — balancing high-growth bets with more defensive, cash-flow-focused assets.
A Near-4,000% Bet on Ingevity Corporation
Rockefeller's biggest move by far was in Ingevity (NGVT). The firm added 92,516 shares in Q4, bringing its total to 94,830 shares. That is a 3,998.1% increase — essentially a brand-new position, per watchlistnews.com. The stake is valued at around $5.61 million. Institutional investors as a group own about 91.59% of the company's stock.
Wall Street has taken notice. Wells Fargo raised its price target on NGVT to $75. BMO Capital Markets reaffirmed an "Outperform" rating. Wall Street Zen upgraded the stock to a strong buy. Ingevity makes activated carbon and pavement materials — products tied to emissions control and infrastructure spending. Some analysts caution that the company's heavy reliance on the auto sector could be a risk if consumer spending slows.
Gold Miners and Global Growth Get Major Boosts
Rockefeller nearly doubled its stake in the VanEck Junior Gold Miners ETF (GDXJ), adding 24,127 shares in Q4 for a total of 49,351 shares worth about $5.62 million — a 95.7% increase, according to tickerreport.com. GDXJ opened at $100.29, well below its 50-day moving average of $114.31 and its 200-day moving average of $122.50. The move is seen as a hedge against rising geopolitical risk and falling Treasury yields.
Rockefeller also boosted its stake in the Capital Group Global Growth Equity ETF (CGGO) by 60%, adding 62,320 shares to reach a total of 166,190 shares worth $5.76 million. CGGO carries a market cap of around $11.15 billion, a P/E ratio of 22.37, and a beta of 1.02. The fund's top holdings include major semiconductor names, aligning with Rockefeller's interest in technology beyond the largest players.
Cash Cows and ESG Stocks Round Out the Strategy
The firm's largest percentage increase among ETFs was in the Pacer Global Cash Cows Dividend ETF (GCOW). Rockefeller added 78,403 shares — a 118.8% jump — bringing its total to 144,415 shares worth $5.95 million, per watchlistnews.com. GCOW opened at $43.66, below its 50-day moving average of $45.51. The fund has a low beta of 0.69 and a P/E of just 12.82, making it one of the more defensive positions in the portfolio.
Rockefeller also raised its stake in the iShares MSCI USA ESG Select ETF (SUSA) by 14.8%, adding 5,057 shares to reach 39,240 shares valued at $5.47 million. ESG funds — which screen companies based on environmental, social, and governance standards — have faced political pressure in some regions. But the steady increase shows Rockefeller sees long-term value in maintaining that exposure.
What the Moves Say About Rockefeller's Broader Strategy
The Q4 filings paint a picture of a firm running what analysts call a "barbell" strategy. On one end: high-growth, globally diversified bets like CGGO and NGVT. On the other: defensive, income-focused plays like GCOW and GDXJ. Rockefeller also expanded positions in On Holding AG by 117.6% and Corteva by 40.9%, per tickerreport.com, showing the firm is active across sectors.
Analysts watching the NGVT position will look to the $85.50 consensus price target as a key test. If Ingevity reaches that level, it would validate Rockefeller's deep-value entry and could draw similar moves from other large institutional investors. For now, the Q4 filings show a firm placing big, confident bets across a wide range of assets.
Sentiment
Mostly PositivePublishers
24
Articles
8
Reach
32
